Biallelic TXNIP deficiency is associated with a multisystemic metabolic disease
Open Access
- 14 July 2026
- journal article
- Published by Elsevier in Molecular Metabolism
- Vol. 111, 102414
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 54 references indexed in Scilit:
- Exploring Thioredoxin‐Interacting Protein (TXNIP) as a Therapeutic Target for Cardiovascular DiseasesArchiv der Pharmazie, 2025
- TXNIP interaction with GLUT1 depends on PI(4,5)P2Biochimica et Biophysica Acta (BBA) - Biomembranes, 2021
- Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to InsulinCell Reports, 2017
- FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose TissuesCell Metabolism, 2016
- Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose IntoleranceCell Metabolism, 2014
- Functions of plasmalogen lipids in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Can we exclude theTXNIP gene as a candidate gene for familial combined hyperlipidemia?American Journal of Medical Genetics Part A, 2006
- Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemiaAmerican Journal of Medical Genetics Part A, 2004
- TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart StudyAtherosclerosis, 2004
- Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994